Infused beers and wines are offering consumers a new alternative to alcoholic beverages.

Vaping products, one of the fastest-growing segments of the legal marijuana industry, have taken a hit from consumers as public health experts scramble to determine what's causing a mysterious and sometimes fatal lung disease among people who use e-cigarettes.

The ailment has sickened at least 530 people and killed nine. Some vaped nicotine, but many reported using oil containing THC, marijuana's high-inducing ingredient, and said they bought products from pop-up shops and other illegal sellers. The only death linked to THC vapes bought at legal shops occurred in Oregon.

Amid the health scare, the amount of the legal pot industry's revenue that comes from vape products has dropped by 15% nationwide, with some states, including Oregon, seeing decreases of more than 60%.

The marijuana stock market has shifted dramatically over the course of the past few years. In that time, we have seen the industry become more friendly to outside investors, allowing pot stocks to flourish, and new technology to become more available than ever. With so many different pot stocks to watch in the market, it can be a daunting task to pick just one.

Although it isn’t classified as an illness, psychosis is a serious mental condition that requires attention.

When talking about psychosis triggered by the use of cannabis, it’s important to note that this acute state can manifest with severe symptoms, but will usually resolve once the drug is out of the system.

When you consume cannabis, how often do you think about its flavour?

Sure, most may take a whiff at a dispensary to help the decision-making, but is it the main reason one reaches for the bud when it is time to toke?

I imagine the answer for many would be no.

But for a handful of industry professionals, they are staking their careers on a passion for the rich flavours and smells cannabis can produce — and hoping others can be persuaded to feel the same way.

From cannabis sommelier courses to new “elevated” dining experiences, they are taking cannabis and flavour to the next level.

A brain protein associated with depression and Alzheimer’s in young marijuana users has now also been linked to stress and anxiety.

Previous studies have shown that marijuana can reduce stress and quell anxiety in adults. New Canadian research indicates the same might not be true for adolescents. Instead, young cannabis users often develop a brain protein associated with stress and anxiety, according to the study.

The marijuana stock market has shifted very rapidly over the course of the past few years. With so many pot stocks to watch and pot stocks to choose from, it seems as though the choice can be quite difficult. This choice, however, is just the reason you’re here. One of the key things to note about pot stocks is that they come from all around the industry. Companies in the cannabis stock market can be ancillary businesses such as marketing and packaging companies.

You may be able to improve how well CBD is absorbed by the body and delivered to your bloodstream by using CBD with food.

Now that you know what CBD oil is, how it’s different from hemp oil, and you’ve discovered the natural benefits of regularly taking CBD oil, you’re likely curious as to whether there are ways to maximize the effectiveness of your daily CBD supplement. 

Profits have been elusive for many companies in the cannabis industry. With federal law making it impossible for companies to expand their operations across the U.S without either acquiring a company in another state or setting up an entirely new operation, it's been very difficult for costs to stay at manageable levels. The one workaround, however, has been for companies like Charlotte's Web (OTC:CWBHF) that have chosen a different route: hemp.

Purdue Pharma, the company that made billions selling the prescription painkiller OxyContin, filed for bankruptcy in White Plains, New York, days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids.

The filing was anticipated before and after the tentative deal, which could be worth up to $12 billion over time, was struck.